{
    "Additional Indicators": [
        {
            "description": "Unfavorable Prognosis",
            "therapy": "NCCN, Consensus, Non-Small Cell Lung Cancer",
            "mutation": "KRASp.G12C Gain-of-function"
        }
    ],
    "Clinical trials": [
        {
            "description": "A Study of VS-6766 v. VS-6766 + Defactinib in Recurrent G12V, Other KRAS and BRAF Non-Small Cell Lung Cancer ",
            "phase": "Phase 2",
            "mutations": [
                "KRAS"
            ]
        },
        {
            "description": "A Phase 1/2 Study of MRTX849 in Patients With Cancer Having a KRAS G12C Mutation KRYSTAL-1",
            "phase": "Phase 1/2",
            "mutations": [
                "KRAS",
                "STK11"
            ]
        },
        {
            "description": "First-in-human Study of DRP-104 (Sirpiglenastat) as Single Agent and in Combination With Atezolizumab in Patients With Advanced Solid Tumors. (NCT04471415)",
            "phase": "Phase 1/2",
            "mutations": [
                "NFE2L2",
                "STK11"
            ]
        }
    ],
    "variants of unknown significance": {
        "Somatic": [
            {
                "Gene": "FGFR3",
                "DNA Alteration": "c.1138G>A",
                "GeneMutation": "p.R248C Stopgain-LOF",
                "VariantAlleleFraction": "18.87%"
            },
            {
                "Gene": "IDH2",
                "DNA Alteration": "c.515G>A",
                "GeneMutation": "p.R140L Spliceregionvariant-LOF",
                "VariantAlleleFraction": "7.92%"
            },
            {
                "Gene": "KLF4",
                "DNA Alteration": "c.1225A>C",
                "GeneMutation": "p.K409Q Nonsense-GOF",
                "VariantAlleleFraction": "3.74%"
            },
            {
                "Gene": "NCSTN",
                "DNA Alteration": "c.3113A>G",
                "GeneMutation": "p.A572G Spliceregionvariant-GOF",
                "VariantAlleleFraction": "8.64%"
            },
            {
                "Gene": "U2AF1",
                "DNA Alteration": "c.3113A>G",
                "GeneMutation": "p.Q157X Nonsense-GOF",
                "VariantAlleleFraction": "1.22%"
            },
            {
                "Gene": "HSD3B1",
                "DNA Alteration": "c.1100=",
                "GeneMutation": "p.T367= Spliceregionvariant-GOF",
                "VariantAlleleFraction": "6.81%"
            },
            {
                "Gene": "ARHGAP45",
                "DNA Alteration": "c.416G>A",
                "GeneMutation": "p.R139H Frameshift-LOF",
                "VariantAlleleFraction": "8.19%"
            },
            {
                "Gene": "HSD3B1",
                "DNA Alteration": "c.1100=",
                "GeneMutation": "p.T367= Spliceregionvariant-LOF",
                "VariantAlleleFraction": "8.58%"
            },
            {
                "Gene": "PDGFRA",
                "DNA Alteration": "c.1153_1154delinsTT",
                "GeneMutation": "p.D842V Frameshift-LOF",
                "VariantAlleleFraction": "4.59%"
            }
        ],
        "Germline": []
    }
}